María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer

María Natalia Gandur Quiroga recently shared a post on LinkedIn:

“Study Uncovers Mutations and DNA Structures Driving Bladder Cancer.

• New mutations and DNA structures drive bladder cancer, according to a study from Weill Cornell Medicine and the New York Genome Center.
• APOBEC3 antiviral enzymes mutate DNA, triggering early-stage bladder cancer.
• Cisplatin chemotherapy causes bursts of mutations, helping cancer cells resist treatment.
• Extrachromosomal circular DNA (ecDNA) promotes therapy resistance in bladder cancer.
• This study highlights new therapeutic strategies for a hard-to-treat cancer.”